A64T (p.Ala64Thr) variant of MFN2 (Mitofusin-2)

A64T (p.Ala64Thr) in MFN2 (Mitofusin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not provided; Charcot-Marie-Tooth disease type 2. The available variant effect predictions contribute to a CATVariant prioritization score of 0.41 / 1. The record also includes population frequency data, published literature, and structural context.

A64T (p.Ala64Thr) variant details